Sepsis Research Blood Sample Collection Services

Agency: DEPT OF DEFENSE
State: Maryland
Type of Government: Federal
FSC Category:
  • A - Research and development
NAICS Category:
  • 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Set Aside: No Set aside used
Posted Date: Sep 1, 2026
Due Date: Oct 15, 2026
Solicitation No: HT942523P0084
Original Source: Please Login to View Page
Contact information: Please Login to View Page
Bid Documents: Please Login to View Page

Description

Follow
Sepsis Research Blood Sample Collection Services
Active
Contract Opportunity
Notice ID
HT942523P0084
Related Notice
Department/Ind. Agency
DEPT OF DEFENSE
Sub-tier
DEFENSE HEALTH AGENCY (DHA)
Office
DEFENSE HEALTH AGENCY
General Information
  • Contract Opportunity Type: Special Notice (Original)
  • Original Published Date: Sep 01, 2026 05:03 pm EDT
  • Original Response Date: Oct 15, 2026 10:00 am EDT
  • Inactive Policy: 15 days after response date
  • Original Inactive Date: Oct 30, 2026
  • Initiative:
    • None
Classification
  • Original Set Aside: No Set aside used
  • Product Service Code: AN11 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH
  • NAICS Code:
    • 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
  • Place of Performance:
    MD 21044
    USA
Description

Notice of Intent (NOI) to Sole Source





Title: Sepsis Research Blood Sample Collection Services





Requiring Activity: Walter Reed Army Institute of Research (WRAIR), Integrative Systems Biology (ISB) Branch





Related Notice: HT942523P0084





Product Service Code (PSC): AN11 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH





North American Industry Classification System (NAICS) Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)





Small Business Size Standard: 1000 employees





The Defense Health Agency Contracting Activity (DHACA) on behalf of the Integrative Systems Biology (ISB) Branch at the Walter Reed Army Institute of Research (WRAIR) intends to extend current contract services as a cost R&D contract on a sole source basis to Medstar Health Research Institute, Inc. (MHRI), 10980 Grantchester Way 7th Fl, Columbia, MD 21044-6097 USA; Cage Code 3J1M2 under the RFO FAR 6.103-1 – Only one responsible source can supply the required products due to the non-commercially available sources of the blood samples the Government is requesting.





Description of Requirement: This is a requirement to extend and re-structure a Firm-Fixed Price contract into a Research and Development (R&D) cost type contract vehicle that will allow the Integrative Systems Biology (ISB) Branch to procure samples from septic and non-septic burn patients along with longitudinal clinical data for the assessment of biomarkers of sepsis for refinement and validation of SeptiBurnAlert program. These blood samples; to include longitudinal clinical data, are currently being collected by MHRI in accordance with an approved Institutional Review Board (IRB) protocol and are actively recruiting subjects for patient samples that meet the specific thermally injured criteria. The Government will convert the current contract from a firm fixed price award to a cost type, RFO part 35 R&D contract to better align the requirement with the Government’s needs.





This special notice of intent is not a request for competitive proposals, and no solicitation document exists for this requirement. Meaningful submissions received in response to this notice will be considered solely for the purpose of determining whether competitive procurement is in the best interest of the Government.





If no meaningful, written submissions are received by the date listed below, after the publication of this notice, the solicitation will be issued as a sole source requirement to Medstar Health Research Institute, Inc. Based on the above information, the only technically acceptable vendor to fulfill this requirement is MHRI.





Submit capability statements (using PDF, MS Word, or Excel attachments) to Ms. Nicole Applegate at e-mail: nicole.v.applegate.civ@health.mil





Capability statements are due no later than 10:00am Eastern Time on October 15, 2026.






Attachments/Links
Contact Information
Contracting Office Address
  • MEDICAL R & D CONTRACTING DIVISION 1 808 SCHREIDER STREET
  • FORT DETRICK , MD 21702
  • USA
Primary Point of Contact
Secondary Point of Contact
History
  • Sep 01, 2026 05:03 pm EDTSpecial Notice (Original)
Get Government Bids Like This by Email Receive daily bid alerts that match your keywords, business categories, and target regions.

See Also

Follow Notice of Intent to Sole Source the Co-sponsorship of a Forum on

DEPT OF DEFENSE

Due by 11/18/2026

Follow Generative Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S. interagency, academic and

DEPT OF DEFENSE

Due by 10/18/2028

Follow Broad Agency Announcement DEVCOM C5ISR RTI Active Contract Opportunity Notice ID W56KGU23RRTID

DEPT OF DEFENSE

Due by 10/31/2027

Follow Broad Agency Announcement DEVCOM C5ISR RTI Active Contract Opportunity Notice ID W56KGU23RRTID

DEPT OF DEFENSE

Due by 10/31/2027

* Disclaimer: This website provides information about bids, requests for proposals (RFPs), or requests for qualifications (RFQs) for convenience only and does not serve as an official public notice. Individuals who wish to respond to or inquire about bids, RFPs, or RFQs should contact the relevant government department directly.